Oxaliplatin versus mitomycin C in HIPEC for peritoneal metastasis from colorectal cancer: a systematic review and meta-analysis of comparative studies.

Xubing ZhangQingbin WuMingtian WeiXiangbing DengChaoyang GuZi-Qiang Wang

Published in: International journal of colorectal disease (2020)

OX and MMC could achieve comparable survival in HIPEC for PM from CRC. However, in consideration of the high incidence of major complication in OX group, MMC might be the safer one in clinical routines.

Keyphrases

particulate matter
air pollution
risk factors
low density lipoprotein
heavy metals
free survival
polycyclic aromatic hydrocarbons
case control
risk assessment
water soluble